By integrating network pharmacology prediction and molecular docking technology, this study is the first to reveal the core mechanism by which IPTF exerts anti-cancer effects through the synergistic regulation of the PI3K/AKT and EGFR-MAPK dual signaling pathways. This evidence concerns the gene AKT1 and cancer.